Testing a cognitive assessment tool for ECT patients
Part of Mental health clinical trials.
This study evaluates a cognitive assessment tool (ECCA) in Turkish patients who are receiving electroconvulsive therapy (ECT), a brain-stimulation treatment for severe depression or other psychiatric conditions. Researchers want to see how well this assessment works and compare it to other existing tests.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have been diagnosed with a condition that your doctor thinks would benefit from ECT (electroconvulsive therapy), based on standard psychiatric diagnostic criteria
- You can read and write in Turkish
- You do not have intellectual disability or significant cognitive impairments before starting treatment
- You do not have a history of neurological disease (such as stroke, Parkinson's, or epilepsy)
- You do not have dementia or substance abuse issues
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how ECT affects brain activity and inflammation in older adults with depression. It may help researchers understand why ECT works and improve treatment.
This study looks at “neural biomarkers,” or brain-measurement signals, to see who is most likely to benefit from electroconvulsive therapy (ECT). It focuses on people with certain active psychosis symptoms and specific mental health diagnoses who have tried antipsychotic medication without enough improvement.
This trial studies better ways to deliver ECT (electroconvulsive therapy) for people with difficult-to-treat depression, including some people with bipolar depression. You may be offered an ECT strategy that’s tailored to your situation, with the goal of improving outcomes and reducing problems.
This study measures changes in your blood and/or body chemistry while you receive electroconvulsive therapy (ECT) for a severe mood episode. The goal is to understand biological signals related to ECT and treatment-resistant depression, which may help improve future care.
This study helps doctors find the best settings for electroconvulsive therapy (ECT), a treatment for severe depression and other mental health conditions. Researchers will use special monitoring equipment to measure brain activity during your ECT sessions to improve how the treatment works.
This study looks for ways to predict how well electroconvulsive therapy (ECT) will work for severe depression. It may help doctors choose the best treatment approach and timing for future patients.
Hear when a new Cognitive Assessment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.